Developer site: The content shown here is test data.

Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Back to skin conditions

Pheochromocytoma risk factors

Introduction

Overview

Overview

The most potent risk factor for pheochromocytoma is a family history of multiple endocrine neoplasias, Von Hippel-Lindau disease, neurofibromatosis type 1, hereditary paraganglioma syndromes.

Risk Factors

Risk Factors

The most potent risk factor in the development of pheochromocytoma is a family history of multiple endocrine neoplasias, Von Hippel-Lindau disease, neurofibromatosis type 1 or hereditary paraganglioma syndromes.

Common Risk Factors

Less Common Risk Factors

  • Less common risk factors in the development of pheochromocytoma include harboring the following genes:
    • SDHA
    • SDHAF2
    • TMEM127 (transmembrane protein 127)
    • MAX (myc-associated factor X)
    • FH (fumarate hydratase)
    • PDH1, PDH2 (pyruvate dehydrogenase)
    • HIF1alpha (hypoxia-inducible factor)
    • MDH2 (malate dehydrogenase)
    • KIF1Bß (kinesin family member) genes. [2]
References

References

  1. ↑ Gimm O (2005). “Pheochromocytoma-associated syndromes: genes, proteins and functions of RET, VHL and SDHx”. Fam Cancer. 4 (1): 17–23. doi:10.1007/s10689-004-5740-1. PMID 15883706.
  2. ↑ Jameson, J (2017). Harrison’s Principles of Internal Medicine 19th Edition and Harrison’s Manual of Medicine 19th Edition VAL PAK. New York: McGraw-Hill Medical. ISBN 978-1260128857.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohammed Abdelwahed M.D[2] Ifrah Fatima, M.B.B.S[3]